BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9625817)

  • 1. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The roles of DNA methylation in human neoplasms].
    Yuan YF; Li JQ; Yang ZL; Wang JP
    Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
    Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas.
    Florl AR; Löwer R; Schmitz-Dräger BJ; Schulz WA
    Br J Cancer; 1999 Jul; 80(9):1312-21. PubMed ID: 10424731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
    Liu L; Yoon JH; Dammann R; Pfeifer GP
    Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
    Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
    Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.
    Auerkari EI
    Oral Oncol; 2006 Jan; 42(1):5-13. PubMed ID: 15978859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and consequences of DNA hypomethylation in human cancer.
    Hoffmann MJ; Schulz WA
    Biochem Cell Biol; 2005 Jun; 83(3):296-321. PubMed ID: 15959557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role and significance of DNA methylation].
    Kowal M; Wojcierowski J
    Pol Merkur Lekarski; 2003 Apr; 14(82):364-8. PubMed ID: 12868204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.